HomeNews

News

Pharmstandard will construct a new production facility in Ufa

The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles. According to Nail Nizamutdinov, General...

Binnopharm Group brings its popular antispasmodic to Azerbaijan

Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin, an antispasmodic with prokinetic effect...

Vladimir Shipkov: Foreign pharmaceutical companies continue to supply medicines to Russia

Foreign pharmaceutical companies continue to work in Russia and supply medicines to the Russian market, Executive Director of the Association of International Pharmaceutical Manufacturers...

Petrovax began supplying quadrivalent influenza vaccine to the Russian market and abroad

The total supply of the vaccine for Russian and foreign markets in 2022 will amount to more than 2.5 million doses

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September 1 and will expire on...

Binnopharm Group’s revenue for 1H 2022 goes up 16.3% to over RUB 12.6 bn

Binnopharm Group, a pharmaceutical company, announces its unaudited consolidated IFRS financial results for the first half ended 30 June 2022. In 1H 2022, the Company’s...
spot_img

Expert Articles

spot_img